Vimarsana
Biggest News Aggregation in the World

Page 5 - Gnubiotics Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gnubiotics Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gnubiotics Sciences Today - Breaking & Trending Today

Animal Microbiome Market worth $12.4 Billion by 2030 - Exclusive Report by InsightAce Analytic - Vimarsana News

Animal Microbiome Market worth $12.4 Billion by 2030 - Exclusive Report by InsightAce Analytic

/PRNewswire/ -- The newly published report titled "Global Animal Microbiome Market– By Trends, Industry Competition Analysis, Revenue (US$ Millions) and...

Animal Microbiome Market worth $12.4 Billion by 2030 - Exclusive Report by InsightAce Analytic - Vimarsana News

Animal Microbiome Market worth $12.4 Billion by 2030 - Exclusive Report by InsightAce Analytic

/PRNewswire/ -- The newly published report titled "Global Animal Microbiome Market– By Trends, Industry Competition Analysis, Revenue (US$ Millions) and...

Gnubiotics Sciences: Animal Milk Oligosaccharides Can Protect Pet's Microbiome During Antibiotic Treatment - Vimarsana News

Gnubiotics Sciences: Animal Milk Oligosaccharides Can Protect Pet's Microbiome During Antibiotic Treatment

A trial has found that Animal Milk Oligosaccharides (A.M.O.s) manufactured by leading Swiss biotech experts Gnubiotics Sciences can help prevent the effects of antibiotics on the gut microbiome. This

Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office - Vimarsana News

Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office USA - English Share this article Share this article LAUSANNE, Switzerland, May 24, 2021 /PRNewswire/ -- Gnubiotics Sciences SA (Gnubiotics), a Swiss biotech company pioneering novel microbiome targeted solutions for humans and companion animals, today announced the allowance from the European Patent Office (EPO) for its patent application 19812838.1 (EPO pubication 3695018). This is a key patent filing covering the microbiome-based prediction, ...

Global Human Microbiome Therapeutics Market Outlook to 2027, By Product, Therapeutic Area, Indication, Approach and Region - Vimarsana News

Global Human Microbiome Therapeutics Market Outlook to 2027, By Product, Therapeutic Area, Indication, Approach and Region

Press release content from Business Wire. The AP news staff was not involved in its creation. Global Human Microbiome Therapeutics Market Outlook to 2027, By Product, Therapeutic Area, Indication, Approach and Region - ResearchAndMarkets.com April 27, 2021 GMT DUBLIN--(BUSINESS WIRE)--Apr 27, 2021-- ADVERTISEMENT The global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects. In November 2019, the Million Microbi...

Source: apnews.com